The Relationship Between Age and Recovery After Spinal Cord Injury
Aug 21, 2026 - 02:34
Radio and PodcastLive Radio & PodcastsHealth
Efficacy and Safety of Cemdisiran siRNA in Myasthenia Gravis
Dr. Aaron S. Zelikovich discusses the phase 3 NIMBLE trial of cemdisiran, an siRNA targeting complement component 5, for the treatment of generalized myasthenia gravis. Show citation: Vu T, Habib AA, Jacob S, et al. Effi...
About This Episode
Efficacy and Safety of Cemdisiran siRNA in Myasthenia Gravis is an episode from Neurology Minute by Anna Rehbein. Dr. Aaron S. Zelikovich discusses the phase 3 NIMBLE trial of cemdisiran, an siRNA targeting complement component 5, for the t...
Podcast
This episode belongs to Neurology Minute.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Aug 12, 2026, 03:00 long, audio available.
Related Episodes
Continue listening to more episodes from Neurology Minute.
Virtual vs In-Person Neurologic Ambulatory Care
Aug 20, 2026 - 01:50
Lab Minute: Tolosa Hunt Syndrome
Aug 19, 2026 - 03:14
Consortium of Neurology Residents and Fellows
Aug 18, 2026 - 03:00
Vamorolone for Duchenne Muscular Dystrophy
Aug 17, 2026 - 02:34
American Epilepsy Society Clinical Practice Guideline - Part 1
Aug 14, 2026 - 01:38
Post-Traumatic Headache in Children and Genetic Risk of Migraine
Aug 13, 2026 - 02:05
Negative Myoclonus
Aug 11, 2026 - 02:53